| Oestrogens reconsidered. | |
| | |
MedLine Citation:
|
PMID: 7754279 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Oestrogen therapy or orchidectomy reigned supreme for the treatment of metastatic prostatic cancer for almost 40 years. In the last 15 years many alternative agents have been tested alone and more recently in combination. This contribution evaluates the results of some of these newer therapies considering relief of symptoms, toxicity, quality of life, survival, and benefit to the community. The results are compared with those of oestrogen therapy and with the way in which such treatment might be amended in light of more modern knowledge. |
| | |
Authors:
|
P H Smith |
Related Documents
:
|
19147869 - Patient adherence and persistence with oral anticancer treatment. 22860099 - Differential proteomic analysis of noncardia gastric cancer from individuals of norther... 3001379 - Immunoaugmentative therapy. a primer on the perils of unproved treatments. 22907789 - Effects of enhanced bolus flavors on oropharyngeal swallow in patients treated for head... 21928249 - Development of a website and biobank database for the nanosized cancer polymarker bioch... 21765659 - Advances in breast cancer detection with screening mammography. 17620279 - The risk of death from heart disease in patients with nonsmall cell lung cancer who rec... 11815299 - Electrophysiologic identification of the location of the colonic pacemakers. a human st... 7373449 - Mortality among workers employed in petroleum refining and petrochemical plants. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Seminars in surgical oncology Volume: 11 ISSN: 8756-0437 ISO Abbreviation: Semin Surg Oncol Publication Date: 1995 Jan-Feb |
Date Detail:
|
Created Date: 1995-06-16 Completed Date: 1995-06-16 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8503713 Medline TA: Semin Surg Oncol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 72-6 Citation Subset: IM |
Affiliation:
|
Department of Urology, St. James's University Hospital, Leeds, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Combined Modality Therapy Estrogens / therapeutic use* Humans Male Neoplasm Metastasis Neoplasm Staging Orchiectomy Prostatic Neoplasms / drug therapy*, mortality, pathology, surgery Randomized Controlled Trials as Topic Risk Factors Survival Rate Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Estrogens |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: European trials and the management of prostate cancer.
Next Document: Anatomy of the prostate and distribution of early prostate cancer.